Clinical Trial Update: Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing ranolazine for reducing chest pain in patients with angina due to blockage but no stents; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: North Florida Foundation for Research and Education | Conditions: Angina | Phase 2 | Status: TERMINATED | Results posted: 2019-06-11